Statistics for ARF6 is a Novel Target for Immunotherapy in Triple Negative Breast Cancer
Total visits
views | |
---|---|
ARF6 is a Novel Target for Immunotherapy in Triple Negative Breast Cancer | 2 |
Total visits per month
views | |
---|---|
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 2 |